Mesna Oral Tablet

Brand(s)
Mesnex
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Baxter Healthcare Corporation (2015-01-31)
Oldest Current Product
2002-03-21
License(s)
NDA
RxNORM
ORAL TABLET\MESNA
FDAOB
ORAL\TABLET\MESNA
SPL Active
ORAL\TABLET, FILM COATED\MESNA
SPL Moiety
ORAL\TABLET, FILM COATED\2-MERCAPTOETHANESULFONIC ACID

product(s) by strength(s)

mesna 400 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1671083565MesnexNDABaxter Healthcare Corporation2002-03-21MESNAORALTABLET, FILM COATEDNDA0208554a51ffdb-f59f-4e02-b3c4-f3457ab7b514

application(s)

#idtitleapplicantapprovedapproved drug
1NDA020855MESNEXBAXTER HEALTHCARE CORP2002-03-21NDA020855_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1NDA020855_001RXMESNA (400MG)ORALTABLETTrue2002-03-21MESNEX

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
14a51ffdb-f59f-4e02-b3c4-f3457ab7b514 (view SPL)These highlights do not include all the information needed to use MESNEX safely and effectively. See full prescribing information for MESNEX. MESNEX (mesna) tablets, for oral useMESNEX (mesna) injection, for intravenous useInitial U.S. Approval: 1988prescriptionHuman PrescriptionBaxter Healthcare CorporationANALYSIS, API MANUFACTURE, LABEL, MANUFACTURE, PACK2015-01-318671083565

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII